What is the current price / NAV of ITI Pharma & Healthcare Fund(IDCW)?
The current NAV of ITI Pharma & Healthcare Fund(IDCW) is ₹18.43, as of 20th May 2026.What are the returns of ITI Pharma & Healthcare Fund(IDCW)?
The ITI Pharma & Healthcare Fund(IDCW) was launched on 8th November 2021. This mutual fund's past returns are as follows:- 1 Year Returns: 7.87%
- 3 Year Returns: 24.39%
What are the top 5 sectoral holdings of ITI Pharma & Healthcare Fund(IDCW)?
The top sectors ITI Pharma & Healthcare Fund(IDCW) has invested in are as follows:- Pharmaceuticals | 68.97%
- Labs & Life Sciences Services | 20.57%
- Others | 3.56%
- Oil & Gas - Refining & Marketing | 1.37%
- Plastic Products | 1.29%
What are the top 5 holdings of ITI Pharma & Healthcare Fund(IDCW)?
The top 5 holdings for ITI Pharma & Healthcare Fund(IDCW) are as follows:- Sun Pharmaceutical Industries Ltd | 12.40%
- Divi's Laboratories Ltd | 8.83%
- Apollo Hospitals Enterprise Ltd | 6.25%
- Max Healthcare Institute Ltd | 5.22%
- Torrent Pharmaceuticals Ltd | 4.82%
What is the asset allocation of ITI Pharma & Healthcare Fund(IDCW)?
The asset allocation for ITI Pharma & Healthcare Fund(IDCW) is as follows:- Equity | 96.90%
- Cash & Equivalents | 3.10%
What is the AUM of ITI Pharma & Healthcare Fund(IDCW)?
The AUM (i.e. assets under management) of ITI Pharma & Healthcare Fund(IDCW) is ₹229.56 Cr as of 20th May 2026.What is the expense ratio of ITI Pharma & Healthcare Fund(IDCW)?
The expense ratio of ITI Pharma & Healthcare Fund(IDCW) Plan is 0.66 as of 20th May 2026.What is the alpha ratio of ITI Pharma & Healthcare Fund(IDCW)?
The alpha ratio for the ITI Pharma & Healthcare Fund(IDCW) is -2.48
Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the volatility or standard deviation of ITI Pharma & Healthcare Fund(IDCW)?
The volatility or standard deviation for the ITI Pharma & Healthcare Fund(IDCW) is 13.31
Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of ITI Pharma & Healthcare Fund(IDCW)?
The Sharpe ratio for the ITI Pharma & Healthcare Fund(IDCW) is 0.25
The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of ITI Pharma & Healthcare Fund(IDCW)?
The Sortino Ratio for the ITI Pharma & Healthcare Fund(IDCW) is 0.03
The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.
What is the Price to Earnings (PE) ratio of ITI Pharma & Healthcare Fund(IDCW)?
The PE ratio of ITI Pharma & Healthcare Fund(IDCW) is 45.04, while category PE ratio is 43.46.

Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%